Company / Book Value per Share
Pfizer Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$15.147
FY2025
5-year range
$13.604 / $16.985
FY2021-FY2025
Trend
-1.5%
vs FY2024
Sector context
#41 of 209
Health Care
What the data says
Pfizer's book value per share of $15.147 is higher than 80% of companies in the Health Care sector (FY2025). Book Value per Share has declined for 3 consecutive years, from $16.985 in FY2022 to $15.147 in FY2025.
Based on SEC 10-K filings.
$15.147 in FY2025 with a 5-year CAGR of +7.4%. Top quartile in the Health Care sector.
Declined from $15.595 to $15.147 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -3.7%
- 5-Year CAGR
- +7.4%
- 10-Year CAGR
- -
Sector benchmark
-92.0% below sector average
Key checks
Key Insights
- Pfizer's book value per share has declined for 3 consecutive years.
- 5-year CAGR of +7.4%, indicating consistent growth.
- In FY2025, book value per share decreased 1.5% year-over-year.
- Ranks #41 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.147 | -1.5% |
| FY2024 | $15.385 | -1.3% |
| FY2023 | $15.595 | -8.2% |
| FY2022 | $16.985 | +24.9% |
| FY2021 | $13.604 | +28.6% |
| FY2020 | $10.58 | +1.5% |
| FY2019 | $10.423 | +1.2% |
| FY2018 | $10.295 | -9.7% |
| FY2017 | $11.397 | +23.0% |
| FY2016 | $9.269 | -1.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026